Test79
codeSystem | codeSystemName and Description | Owner |
---|---|---|
2.16.840.1.113883.6.1 | LOINC Logical Observation Identifier Names and Codes |
Regenstrief Institute |
2.16.840.1.113883.6.8 | UCUM Unified Code for Units of Measure |
Regenstrief Institute, and the UCUM Organization |
2.16.840.1.113883.6.96 | SNOMED-CT Systematized Nomenclature of Medicine – Clinical Terms |
IHTSDO/Snomed International |
1.3.6.1.4.1.19376.1.5.3.2 | IHEActCode Vocabulary defined by IHE PCC in PCC TF-2:5.1.2, used for representing annotation comments in the report |
IHE PCC |
2.16.840.1.113883.5.4 | Act Code Codesystem for Acts |
HL7 International |
2.16.840.1.113883.5.6 | ActClass Codesystem for Act Classes |
HL7 International |
2.16.840.1.113883.5.1052 | Act Site Codesystem for Act Sites |
HL7 International |
2.16.840.1.113883.5.1065 | ProcedureMethod Codesystem for Procedure Methods |
HL7 International |
2.16.840.1.113883.5.111 | Role Code Codesystem for Role Codes |
HL7 International |
2.16.840.1.113883.5.129 | SpecimenType Codesystem for Specimen Types |
HL7 |
2.16.840.1.113883.5.83 | ObservationInterpretation One or more codes specifying a rough qualitative interpretation of the observation, such as "normal", "abnormal", "below normal", "change up", "resistant", "susceptible", etc. |
HL7 International |
2.16.840.1.113883.5.84 | ObservationMethod A code system that provides additional detail about the means or technique used to ascertain the observation |
HL7 International |
2.16.840.1.113883.6.3 | ICD-10 International Classification of Diseases revision 10 |
WHO |
2.16.840.1.113883.6.43 | ICD-O-3 International Classification of Diseases for Oncology revision 3 |
WHO |
1.2.840.10008.2.16.4 | DICOM controlled vocabulary The meanings of codes defined in DICOM, either explicitly or by reference to another part of DICOM or an external reference document or standard [1] |
DICOM |
2.16.840.1.113883.15.6 | TNM 7th edition Internationally agreed-upon standards to describe and categorize cancer stages and progression [2] |
Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC) |
2.16.840.1.113883.15.7 | TNM 6th edition Internationally agreed-upon standards to describe and categorize cancer stages and progression [2] |
Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC) |
2.16.840.1.113883.15.8 | TNM 5th edition Internationally agreed-upon standards to describe and categorize cancer stages and progression [2] |
Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC) |
2.16.840.1.113883.6.4 | ICD-10-PCS International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) |
WHO |
1.2.276.0.76.5.464 | OPS 2017 Code lists to describe and categorize surgeries and procedures, adapted from WHO ICPM for Germany |
DIMDI / (WHO) |
2.16.840.1.113883.6.174 | OMIM Code lists to describe and categorize human genes. OMIM is a comprehensive, authoritative compendium of human genes and genetic phenotypes that is freely available and updated daily. |
OMIM Johns Hopkins University School of Medicine [1] |
1.2.276.0.76.3.1.131.1.5.1 | DKG Coding Scheme Internationally agreed-upon code lists to describe and categorize cancer grading systems, adapted for Germany [3] |
DKG (Deutsche Krebsgesellschaft) |
1.2.276.0.76.5.336 | Grading / Differentiation scheme Code lists to describe and categorize Tumor grading according ICD-O-3, adapted for Germany |
HL7 Germany |
1.2.276.0.76.5.401 | Localization scheme for distant metastases Code lists to describe and categorize localization of metastases according UICC, adapted for Germany |
HL7 Germany |
- ↑ DICOM controlled vocabulary http://nema.org/dicom/dicm]
- ↑ 2,0 2,1 2,2 UICC TNM http://www.uicc.org/resources/tnm
- ↑ CDA Assessment Scales Entry DKG-Labels http://wiki.hl7.de/index.php?title=cdaonk:Assessment_Scales_Entry_(Template)#aus_DKG-Labels_.28OID.3D1.2.276.0.76.3.1.131.1.5.1.29